FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA

Cook Williams Communications, Inc. Investor and Media Relations IR@omeros.com. More News From Omeros Corporation. Get RSS Feed. Omeros Corporation …